News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,647 Results
Type
Article (845)
Company Profile (1)
Press Release (21801)
Section
Business (6420)
Career Advice (11)
Deals (1333)
Drug Delivery (1)
Drug Development (2896)
FDA (426)
Job Trends (249)
News (11273)
Policy (1062)
Tag
Academia (56)
Accelerated approval (1)
Allergies (8)
Alliances (2146)
ALS (8)
Alzheimer's disease (38)
Antibody-drug conjugate (ADC) (13)
Approvals (458)
Artificial intelligence (17)
Autoimmune disease (9)
Automation (1)
Bankruptcy (6)
Best Places to Work (197)
BIOSECURE Act (1)
Biosimilars (9)
Biotechnology (3)
Bladder cancer (17)
Brain cancer (1)
Breast cancer (19)
Cancer (192)
Cardiovascular disease (13)
Career advice (10)
CAR-T (6)
Cell therapy (17)
Clinical research (2560)
Collaboration (58)
Compensation (16)
Complete response letters (2)
COVID-19 (120)
CRISPR (2)
C-suite (21)
Cystic fibrosis (5)
Data (263)
Denatured (2)
Depression (1)
Diabetes (13)
Diagnostics (159)
Digital health (4)
Drug discovery (4)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (10)
Earnings (2540)
Events (2725)
Executive appointments (32)
FDA (547)
Funding (49)
Gene editing (4)
Gene therapy (22)
GLP-1 (13)
Government (140)
Grass and pollen (1)
Guidances (16)
Healthcare (729)
HIV (3)
IgA nephropathy (12)
Immunology and inflammation (4)
Immuno-oncology (1)
Indications (8)
Infectious disease (130)
Inflammatory bowel disease (6)
Influenza (3)
Intellectual property (9)
Interviews (2)
IPO (479)
Job creations (71)
Job search strategy (10)
Kidney cancer (3)
Layoffs (8)
Legal (210)
Longevity (1)
Lung cancer (36)
Lymphoma (29)
Machine learning (1)
Manufacturing (32)
MASH (7)
Medical device (427)
Medtech (429)
Mergers & acquisitions (895)
Metabolic disorders (28)
Multiple sclerosis (10)
Neurodegenerative disease (9)
Neuropsychiatric disorders (2)
Neuroscience (80)
NextGen: Class of 2026 (87)
Non-profit (61)
Obesity (8)
Opinion (1)
Ovarian cancer (3)
Pain (4)
Pancreatic cancer (6)
Parkinson's disease (12)
Patents (17)
Patient recruitment (18)
Peanut (5)
People (1789)
Pharmaceutical (1)
Phase 1 (757)
Phase 2 (1110)
Phase 3 (930)
Pipeline (242)
Policy (1)
Postmarket research (66)
Preclinical (315)
Press Release (3)
Prostate cancer (14)
Radiopharmaceuticals (11)
Rare diseases (30)
Real estate (162)
Regulatory (886)
Reports (1)
Research institute (49)
RSV (1)
Schizophrenia (5)
Series A (11)
Series B (7)
Sickle cell disease (5)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (108)
Supply chain (4)
Vaccines (59)
Venture capital (2)
Weight loss (2)
Women's health (3)
Date
Today (6)
Last 7 days (19)
Last 30 days (70)
Last 365 days (1043)
2026 (100)
2025 (1083)
2024 (1276)
2023 (1421)
2022 (2570)
2021 (2510)
2020 (1730)
2019 (1144)
2018 (938)
2017 (1220)
2016 (938)
2015 (1066)
2014 (844)
2013 (652)
2012 (709)
2011 (810)
2010 (745)
Location
Africa (38)
Arizona (6)
Asia (854)
Australia (171)
California (344)
Canada (88)
China (24)
Colorado (2)
Connecticut (4)
Delaware (8)
Europe (10125)
Florida (17)
Georgia (3)
Idaho (4)
Illinois (20)
India (3)
Indiana (10)
Japan (13)
Louisiana (1)
Maine (1)
Maryland (24)
Massachusetts (178)
Michigan (5)
Minnesota (14)
Nevada (2)
New Jersey (59)
New Mexico (1)
New York (55)
North Carolina (21)
Northern California (144)
Ohio (3)
Oregon (1)
Pennsylvania (27)
South America (154)
Southern California (182)
Tennessee (7)
Texas (20)
United States (826)
Utah (1)
Virginia (5)
Washington D.C. (2)
Washington State (3)
22,647 Results for "carmat sas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Battelle Named Key Subcontractor to SA-TECH for Mission Support Services Contract at U.S. Army Dugway Proving Ground
January 30, 2026
·
3 min read
Press Releases
POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar
November 24, 2025
·
19 min read
Press Releases
Moolec Science S.A. Receives Nasdaq Staff Memo Supporting Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders’ Equity Requirement
January 26, 2026
·
4 min read
Press Releases
Urteste S.A. launches European multicenter clinical study of the Panuri test
November 7, 2025
·
4 min read
Heart Failure Patients Take Heart as Carmat’s Bioprosthetic Implanted into First Woman
French artificial heart maker Carmat announced Tuesday that it had successfully implanted its Aeson artificial heart into the chest cavity of a 57-year-old woman.
September 21, 2021
·
2 min read
·
Heather McKenzie
Press Releases
Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025
July 22, 2025
·
4 min read
Press Releases
Ipsen S.A. - Annual General Meeting held on 21 May 2025
May 22, 2025
·
6 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
1 of 2,265
Next
